Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.

Members of the Cambridge Clinical Multiple Sclerosis Research Group pose for a team photo at ECTRIMS 2025.

Our Research Themes

Personalised Treatments in MS

We are using big data and cutting-edge artificial intelligence to identify the right drug, for the right person at the right time.

Learn more

Clinical Trials & Remyelination

We are conducting groundbreaking research in the field of remyelination, dedicated to repairing the nervous system.

Learn more

Ageing &
Brain Health

We are elucidating the relationship between biological ageing, neurological repair and neuronal loss to identify novel treatment pathways.

Learn more

Latest News

Our Team At MSToronto2026

26th October 2026

Our research team was delighted to attend MSToronto2026, the 10th joint meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in Toronto.

Our team contributed strongly to the scientific programme with multiple team members involved in oral and poster presentations.

Learn more

Public Collaborators

People living with multiple sclerosis are partners in our research: helping shape the questions, the science and the impact.

We recognise that we cannot truly understand the needs of people living with MS in our community unless our Public Collaborators Council has representatives from diverse backgrounds and life experiences, including often overlooked groups.

Learn more